Tandem Diabetes Care Inc (NASDAQ:TNDM) saw a downside of -3.06% to close Friday at $20.59 after subtracting -$0.65 on the day. The 5-day average trading volume is 1,044,040 shares of the company’s common stock. It has gained $23.10 in the past week and touched a new high 2 times within the past 5 days. An average of 1,403,030 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,407,384.
TNDM’s 1-month performance is -27.09% or -$7.74 on its low of $20.54 reached on 09/22/23. The company’s shares have touched a 52-week low of $21.01 and high of $58.82, with the stock’s rally to the 52-week high happening on 01/05/23. YTD, TNDM has lost -54.19% or -$24.36 and has reached a new high 3 times. However, the current price is down -64.99% from the 52-week high price.
Insider Transactions
TNDM stock investors last saw insider trading activity on Sep 15.BERGER DAVID B (EVP & Chief Operating Officer) most recently sold 10,000 shares at $41.19 per share on Mar 03. This transaction cost the insider $411,884. EVP & Chief Operating Officer, BERGER DAVID B, sold 10,000 shares at a price of $40.25 on Dec 16. Then, on Dec 15, EVP & Chief Operating Officer BERGER DAVID B sold 15,000 shares at a price of $40.32 per share. This transaction amounted to $604,800.
Valuation Metrics
TNDM stock has a beta of 0.92. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.70 while the price-to-book (PB) in the most recent quarter is 4.07.
Tandem Diabetes Care Inc’s quick ratio for the period ended June 29 was 3.53, with the current ratio over the same period at 4.38. As well, the company’s long term debt to equity for the quarter ending June 29 was 1.22, while the total debt to equity was 1.28. In terms of profitability, the gross margin trailing 12 months is 51.19%. The firm’s gross profit as reported stood at $412.99 million against revenue of $801.22 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 57.91% to -$35.78 million, while revenue of -$123.87 million was -246.2% off the previous quarter. Analysts expected TNDM to announce -$0.53 per share in earnings in its latest quarter, but it posted -$0.3, representing a 43.40% surprise. EBITDA for the quarter stood at more than -$32.59 million. TNDM stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 617.44 million, with total debt at $420.28 million. Shareholders hold equity totaling $65.08 million.
Let’s look briefly at Tandem Diabetes Care Inc (TNDM) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 September was 26.49% to suggest the stock is trending oversold, with historical volatility in this time period at 51.02%.
The stock’s 5-day moving average is $21.75, reflecting a -5.33% or -$1.16 change from its current price. TNDM is currently trading -24.33% above its 20-day SMA, -48.49% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -30.42% and SMA200 by-51.48%.
Stochastic %K and %D was 8.72% and 12.30% and the average true range (ATR) pointed at 1.55. The RSI (14) points at 30.44%, while the 14-day stochastic is at 0.63% with the period’s ATR at 1.63. The stock’s 9-day MACD Oscillator is pointing at -0.72 and -1.92 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Tandem Diabetes Care Inc (NASDAQ: TNDM), Citigroup downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for TNDM stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate TNDM as a “sell,”, while 9 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 1 rates the stock as overweight while 7 have offered a “buy” rating.
What is TNDM’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $30.00 and a high of $62.00, with their median price target at $37.00. Looking at these predictions, the average price target given by analysts is for Tandem Diabetes Care Inc (TNDM) stock is $42.43.
